Skip to content
Search

Latest Stories

India's health ministry calls for blocking Juul's entry

INDIA'S health ministry has called for Juul Labs Inc's electronic cigarettes to be blocked from entering the country, a letter seen by Reuters showed, potentially dealing a blow to the US company's plans to tap the South Asian market.

Juul has plans to launch its products in India by late 2019 as it looks to expand away from its home turf. The company has hired new executives and plans to open an India subsidiary.


India's top health official wrote a letter to the federal commerce secretary in February, saying necessary measures should be taken to "prevent entry of such products in our markets".

"Novel products such as 'JUUL' are harmful and addictive and could potentially undermine our tobacco control efforts," health secretary Preeti Sudan wrote in her letter dated February 18.

"It is felt that the young generation would be particularly vulnerable to such products and gimmicks."

Asked for a comment on the letter, Juul spokeswoman Victoria Davis said the company was "open to dialogue with lawmakers and regulators in order to help switch" adult smokers in India to a viable alternative to combustible cigarettes.

Juul has previously said India was among the Asian markets under evaluation, but there were no "definitive plans".

The details of Sudan's letter have not previously been reported. She also sent a copy to prime minister Narendra Modi's office.

Juul's sleek vaping devices, which resemble a USB flash drive and offer flavours such as mango and creme, are a sensation in the US, but have drawn tighter regulatory scrutiny due to surging use among teenagers.

However, India's regulatory environment for tobacco and electronic cigarettes is highly restrictive. The health ministry last year advised states to stop the sale or import of e-cigarettes, saying they pose a "great health risk". About a third of India's 29 states currently ban e-cigarettes.

In February, India's federal drugs regulator told all states to ensure that e-cigarettes were not sold or manufactured in their regions, according to a circular.

Advocates for the devices say e-cigarettes are far less harmful, because users do not inhale the dangerous matter taken into the lungs through cigarette smoking. But many tobacco-control activists are opposed to e-cigarettes, saying they could lead to nicotine addiction and push people to consume tobacco.

Juul has said its mission was to "improve the lives of the world's one billion smokers by offering a satisfying alternative to combustible cigarettes".

Indian health secretary Sudan, however, said in her letter that products such as Juul would hurt India's anti-tobacco efforts through their "easy availability, disguised appearance and the false notion of being safe".

More than 900,000 people die each year in India due to tobacco-related illnesses.

(Reuters)

More For You

Narayana Health enters UK market through Practice Plus Group acquisition

The acquisition brings 12 hospitals and surgical centres under Narayana Health’s umbrella, specialising in orthopaedics, ophthalmology and general surgery.

Getty Images

Narayana Health enters UK market through Practice Plus Group acquisition

Highlights

  • Narayana Health acquires Practice Plus Group’s 12 UK hospitals and surgical centres.
  • Deal positions Indian healthcare provider among top three in India by revenue
  • Group plans 1,400 new beds across six greenfield hospitals in India within 30 months.

Narayana Health, one of India’s largest healthcare providers founded by renowned cardiac surgeon Dr Devi Prasad Shetty, has acquired UK-based Practice Plus Group Hospitals, marking its entry into the British healthcare market.

The acquisition brings 12 hospitals and surgical centres under Narayana Health’s umbrella, specialising in orthopaedics, ophthalmology and general surgery. Practice Plus Group, the fifth largest private hospital group in the UK, performs approximately 80,000 surgeries annually.

Keep ReadingShow less